Vivos Therapeutics, Inc. - stock earnings
VVOS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -2.1 million USD | 3.3 million USD |
| 2023Q2 | -5.5 million USD | 3.4 million USD |
| 2023Q1 | 4.8 million USD | 3.9 million USD |
| 2022Q4 | -7.3 million USD | 4.0 million USD |
| 2022Q3 | -7.0 million USD | 4.2 million USD |
| 2022Q2 | -7.0 million USD | 4.2 million USD |
| 2022Q1 | -4.2 million USD | 3.5 million USD |
| 2021Q4 | -20.3 million USD | 4.4 million USD |
| 2021Q3 | -5.5 million USD | 4.5 million USD |
| 2021Q2 | -4.0 million USD | 4.5 million USD |
| 2021Q1 | -3.4 million USD | 3.4 million USD |
| 2020Q4 | -6.2 million USD | 3.3 million USD |
| 2020Q3 | -1.8 million USD | 3.3 million USD |
| 2020Q2 | -1.4 million USD | 3.3 million USD |
| 2020Q1 | -2.6 million USD | 3.2 million USD |
| 2019Q4 | -2.6 million USD | 3.1 million USD |
| 2019Q3 | -3.1 million USD | 3.3 million USD |
VVOS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -15.4 million USD | 14.5 million USD |
| 2022 | -22.7 million USD | 16.0 million USD |
| 2021 | -20.3 million USD | 16.9 million USD |
| 2020 | -8.8 million USD | 13.1 million USD |
| 2019 | -10.9 million USD | 11.4 million USD |
| 2018 | -8.5 million USD | 3.8 million USD |
VVOS
Price: $2.63
52 week price:
Earnings Per Share: -11.14 USD
P/E Ratio: -0.38
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 77800
Market Capitalization: 7.9 million